APA (7th ed.) Citation

Qiao, M., Qiao, M., Wang, B., Fan, J., Gao, F., Wang, S., . . . Xia, S. Inhibition of histone methyltransferase G9a promotes the osteogenic potential of bone-derived stem cells in diabetic-osteoporosis by regulating the LINC00657/miR-204-5p/IGFBP5 pathway. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Qiao, Mei-qi, Mei-qi Qiao, Bin Wang, Jian-pin Fan, Feng Gao, Shao-jun Wang, Sheng-yang Guo, Sheng-li Xia, and Sheng-li Xia. Inhibition of Histone Methyltransferase G9a Promotes the Osteogenic Potential of Bone-derived Stem Cells in Diabetic-osteoporosis by Regulating the LINC00657/miR-204-5p/IGFBP5 Pathway. Frontiers Media S.A.

MLA (9th ed.) Citation

Qiao, Mei-qi, et al. Inhibition of Histone Methyltransferase G9a Promotes the Osteogenic Potential of Bone-derived Stem Cells in Diabetic-osteoporosis by Regulating the LINC00657/miR-204-5p/IGFBP5 Pathway. Frontiers Media S.A.